Blog Posts
Paolo Tarantino
Photo from Paolo Tarantino/Twitter

Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino

With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year.Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year - Paolo Tarantino

Source: Paolo Tarantino / Twitter

breast oncology cancer clinical trials ESMO23 OncoDaily Oncology Paolo Tarantino